Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSheng Liu

About this trial

The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.

Eligibility criteria

Qualifiers

Diagnosed with chronic primary degenerative mitral regurgitation by the preoperative echocardiogram.

Informed consent was obtained

Disqualifiers

Re-operation of mitral regurgitation

Concurrent surgical plan for congenital heart disease, coronary artery bypass grafting, aortic valve surgery, radiofrequency ablation of atrial fibrillation and other cardiac surgeries.

Mitral valve replacement

Unable to undergo TEE

Trial design

Treatments tested in this trial

  • RT3D-TEE-guided mitral valve repair

Treatment groups

338 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sheng Liu

Lead sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Sponsor institution